• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1997 Fiscal Year Final Research Report Summary

Relationship Between the Alteration of Apoptosis Related Genes and Sensitivity for Radiotherapy and Chemotherapy in Human Cancer

Research Project

Project/Area Number 07671368
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionUniversity of Tokyo

Principal Investigator

TOMINAGA Osamu  University of Tokyo, Department of Surgery, Assistant, 医学部・附属病院, 助手 (10261976)

Co-Investigator(Kenkyū-buntansha) OSADA Takuya  University of Tokyo, Department of Sugery, Assistant, 医学部・附属病院, 助手 (90272559)
ISHIMARU Gosei  University of Tokyo, Department of Sugery, Assistant, 医学部・附属病院, 助手 (70272557)
SETO Yasuyuki  University of Tokyo, Department of Surgery, Assistant, 医学部・附属病院, 助手 (00260498)
NAGAWA Hirokazu  University of Tokyo, Department of Surgery, Assistant Proffesor, 医学部・附属病院, 助教授 (80228064)
Project Period (FY) 1995 – 1997
KeywordsApoptosis / Radiotherapy / Chemotherapy / Cancer / Bcl-2 / p53
Research Abstract

P53, p21^<WAF1/CIP1>, Bcl-2 and Bax were analyzed in esophageal and colorectal cancer cell lines. p53 and p21^<WAF1/CIP1> were expressed in about 70% and 40% of the cell lines respectively. Bcl-2 was expressed in the majority of the esophageal cancer cell lines and a few colorectal cancer cell lines. Bax was detected in most of the cell lines studied. To search for the determinant factors of radiosensitivity in rectal carcinoma, p53, p21 and Bcl-2 were selected for possible predictive factors for rediosensitivity. Expressions of p53, p21 and Bcl-2were studied in 49 rectal carcinomas by immunohistochemistry before (biopsy specimen) and after (resected specimen) radiatiion and their relations with pathologic effect of rediotherapy. The total dose of rediation was =0Gy in all patients, by 2.5Gy each time, 5 times a week. p53, p21/WAF1 and Bcl-2 expressions were 53.1%, 30.6% and 71.4%, respectively. There was a significant inverse correlation between the expression of p53 and p21. Moderate to marked pathologic effect of radiation was found in 36.7% of the tumors, while others showed little effect. Of the p53 positive tumors, 88.5% were radioresistant, while 65.2% of the p53 negative tumors were radiosensitive. Of the p21 positive tumors, 80,0% were radiosensitive, while 82.4% of the p21 negative tumors were radioresistant. The combinations of p53 (+) and p21 (-) , as a predictor of radioresistance, and p53 (-) and p21 (+), as a predictor of radiosensitivity, enhanced sensitivity (90.0%), specificity (95.4%) and accuracy (93.8%). The expression of Bcl-2 showed no correlation with radiosensitivity. Immunochemically detected p53 and p21 expression can be used as independent predictors for radiosensitivity of redctal carcinoma. The combination of these two factors can make the selection for radiosensitive tumor more sensitive, specific and accurate.

  • Research Products

    (10 results)

All Other

All Publications (10 results)

  • [Publications] Nita M.E.: "Alterations of cell cycle and apoptosis regulators in esophageal and colorectal cancer cell lines." Recent Advances in Gastroenterological Carcinogenesis. I. 439-443 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tominaga, O.: "Expressions of cell cycle regulators in human colorectal cancer cell lines." Japanese Journal of Cancer Research. 88. 855-860 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Fu C.G.: "Role of p53、p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients." Disease of Colon Rectum. 41. 68-74 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tominaga, O.: "Screening for APC mutations based on the detection of truncated APC proteins." Digestive Diseases and Sciences. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nita M.E.: "Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer." Hepato-Gastroenterology. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nita M.E., Tominiga O., Nagawa H., Kaizaki, S., Fujii S., Yuan X., Tsuno N., Fu C.G., & Muto T: "Alterations of cell cycle and apoptosis regulators in esophageal and colorectal cancer cell lines" Recent Advances in Gastroenterological Carcinogenesis Monduzzi Editore, Bologna. I. 439-433 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tominaga O., Nita M.E., Nagawa H., Fujii S., Tsuruo T.& Muto T.: "Expressions of cell cycle regulators in human colorectal cancer cell lines" Jpn.J.Cancer Res.88. 855-860 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Fu C.G., Tominaga O., Nagawa H., Nita M.E., Higuchi Y., Tsuruo T.& Muto T.: "Role of p53, p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients." Dis.Colon Rectum. 41. 68-74 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tominaga O., Nita M.E., Nagawa H., & Muto T.: "Screening for APC mutations based on the detection of truncated APC proteins" Digestive Diseases and Sciences. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nita M.E., Tominaga O., Nagawa H., Tsuruo T.& Muto T.: "Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer" Hepato-Gastroenterology. (in press).

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-03-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi